Hummer Financial Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.53M | Buy |
8,220
+20
| +0.2% | +$3.71K | 1.15% | 18 |
|
2025
Q1 | $1.72M | Buy |
8,200
+100
| +1% | +$21K | 1.4% | 14 |
|
2024
Q4 | $1.44M | Sell |
8,100
-100
| -1% | -$17.8K | 1.14% | 17 |
|
2024
Q3 | $1.62M | Hold |
8,200
| – | – | 1.27% | 16 |
|
2024
Q2 | $1.41M | Sell |
8,200
-100
| -1% | -$17.2K | 1.22% | 17 |
|
2024
Q1 | $1.51M | Buy |
8,300
+260
| +3% | +$47.3K | 1.25% | 16 |
|
2023
Q4 | $1.25M | Hold |
8,040
| – | – | 1.14% | 16 |
|
2023
Q3 | $1.2M | Hold |
8,040
| – | – | 1.22% | 16 |
|
2023
Q2 | $1.08M | Hold |
8,040
| – | – | 1.06% | 18 |
|
2023
Q1 | $1.28M | Buy |
8,040
+200
| +3% | +$31.9K | 1.36% | 14 |
|
2022
Q4 | $1.27M | Hold |
7,840
| – | – | 1.39% | 13 |
|
2022
Q3 | $1.05M | Hold |
7,840
| – | – | 1.24% | 17 |
|
2022
Q2 | $1.2M | Sell |
7,840
-200
| -2% | -$30.6K | 1.36% | 11 |
|
2022
Q1 | $1.3M | Buy |
8,040
+640
| +9% | +$104K | 1.18% | 14 |
|
2021
Q4 | $1M | Sell |
7,400
-640
| -8% | -$86.7K | 0.84% | 26 |
|
2021
Q3 | $867K | Hold |
8,040
| – | – | 0.8% | 27 |
|
2021
Q2 | $906K | Hold |
8,040
| – | – | 0.84% | 27 |
|
2021
Q1 | $870K | Buy |
8,040
+100
| +1% | +$10.8K | 0.85% | 26 |
|
2020
Q4 | $851K | Sell |
7,940
-200
| -2% | -$21.4K | 0.89% | 24 |
|
2020
Q3 | $713K | Sell |
8,140
-400
| -5% | -$35K | 0.84% | 24 |
|
2020
Q2 | $838K | Buy |
8,540
+100
| +1% | +$9.81K | 1.07% | 16 |
|
2020
Q1 | $643K | Buy |
8,440
+200
| +2% | +$15.2K | 0.97% | 22 |
|
2019
Q4 | $730K | Buy |
+8,240
| New | +$730K | 0.79% | 31 |
|